SAIC Stopped Shrinking. Bookings Decide Whether the Rebound Lasts.

Science Applications International (SAIC) reported its fiscal second quarter before the open Monday, and the market reacted to two different reports at once. On paper it was a beat-and-raise: revenue of $1.88 billion grew 6.3% from a year ago, while adjusted earnings per share came in at $3.01 against a consensus around $2.30, and management lifted its full-year profit guidance for the second straight quarter, raising revenue guidance to $7.2 billion–$7.3 billion, adjusted EBITDA to $750 million–$755 million, and adjusted EPS to $10.65–$10.75. The stock touched a fresh 52-week high in early trading and then faded to about $126, down on the day — even after climbing roughly a third over the past five months.

The number that explains the hesitation sits a few lines below the headline: net bookings of $1.2 billion, a book-to-bill ratio of 0.6 for the quarter and 0.8 over the trailing twelve months. Book-to-bill is the contractor's simplest growth test: above 1.0 means a company booked more new work than it recognized in revenue; below 1.0 means it is running off existing backlog. SAIC's backlog stands at about $22.1 billion, of which only $3.8 billion is funded — the funded part being the work a customer has actually appropriated money for, and it equals roughly two quarters of revenue.

To see why any of this matters, remember how the market got here. Fiscal 2026 was the year SAIC shrank: revenue fell to $7.26 billion from $7.48 billion a year earlier, and hit by procurement delays, unfavorable recompete awards, a government shutdown, and weather disruptions. In February, management cut its fiscal 2027 revenue outlook. At one point over the past twelve months the stock traded as low as the low $80s. The market was pricing the old story of a company in decline.

Underneath, the business was being rebuilt around what it sells. SAIC has shifted away from commodity enterprise-IT contracts — where it kept losing recompetes — toward mission-focused defense, space, and intelligence work, backed by an internal cost program management calls Project Orbit that it says is designed to keep EBITDA margins above 10%. Its qualified pipeline sits near $85 billion. The first half shows the change: organic growth of roughly 0.5% in the first quarter and 5.3% in the second, with part of the reported growth still coming from the small SilverEdge acquisition. For the year, management now guides adjusted EBITDA margin to 10.3%–10.5%, up from fiscal 2026's 9.7%.

But there is an honest problem with treating today as a record. This guidance raise lands adjusted EPS at $10.65–$10.75 — which brackets the $10.75 SAIC just reported for fiscal 2026. Skip the DCF; a forward multiple is enough here. The first half delivered about $6.24 of adjusted EPS — $3.23 in the first quarter, $3.01 in the second — so the full-year map implies the second half runs at barely $2.20 a quarter, roughly 30% below the first half's pace. Management has flagged a roughly $200 million revenue roll-off from a lost recompete, about a 3% organic-growth headwind in each of the next two quarters. Even the quarter just reported, at $3.01, sits below the $3.63 from a year earlier, and that year-ago number was flattered by a patent-settlement cost recovery that did not repeat. The recovery in 2027 is a margin-and-cash story, not a compounding-earnings story.

That is where the hard evidence lives. Fiscal 2026 produced $577 million of free cash flow; fiscal 2027 is guided to more than $600 million, which management frames as at least $14 a share this year and roughly $13 next year, even as tax benefits wind down. Against a market cap of roughly $5.3 billion, that is about an 11% free-cash-flow yield. At $126, the stock trades near 12 times forward adjusted EPS. Not expensive if the trajectory holds; not cheap if bookings keep deteriorating.

The strongest bear argument deserves to be stated plainly: a trailing book-to-bill below 1.0 and a funded backlog of only about two quarters of revenue. Monday's 0.6 means SAIC booked less new work than it recognized in a quarter of strong reported growth. If that persists, fiscal 2028 revenue declines no matter how good margins look, and a 12-times multiple would rest on a shrinking base.

Here is what proves the case either way. The turn holds if book-to-bill climbs back toward 1.0 over the next couple of quarters, funded backlog stabilizes, and free cash flow actually clears $600 million. The case breaks on the opposite: bookings that stay weak, a funded backlog that keeps draining, and cash that falls short of the number. I can be wrong again. But this is now a measurable setup: the market has stopped pricing the old, shrinking SAIC, and whether it should trust the new one comes down to two numbers — the bookings it wins and the cash it turns. Today's report gave us the cash. It left the bookings question open.